Beacon Biosignals · 23 hours ago
Clinical Study Operations Associate
Beacon Biosignals is on a mission to revolutionize precision medicine for the brain, and they are seeking a Clinical Trial Operations Associate to support the deployment of their devices in clinical studies. This role involves collaborating with clinical research sites and project teams to ensure study startup, site management, and compliance with regulatory requirements.
Medical DeviceArtificial Intelligence (AI)HealthcareHealth CareHealth DiagnosticsMachine Learning
Responsibilities
Collaborate with project teams to support study startup activities
Act as the primary point of contact for clinical sites, ensuring smooth operations and clear communication
Provide training to research sites on the use of Beacon’s devices and study protocols, ensuring proper device usage and data collection
Monitor project progress, ensuring adherence to timelines, protocols, and quality standards
Maintain compliance with Good Clinical Practice (GCP), International Conference on Harmonization (ICH) guidelines, and regulatory standards
Address operational issues promptly, escalating through tools like Zendesk and Asana for resolution
Provide actionable feedback from research sites to inform improvements in devices and workflows
Qualification
Required
Experience in clinical project management or clinical operations roles
Strong organizational and project management skills, with the ability to manage multiple responsibilities effectively
Excellent written and verbal communication skills in English; additional languages are a bonus
A proactive mindset with the ability to identify priorities and anticipate challenges
Meticulous attention to detail, ensuring accuracy in data collection and reporting
Familiarity with GCP, ICH guidelines, and clinical research regulatory requirements
A desire to learn more about analytics, statistics, machine learning, and clinical trials
Benefits
Equity
PTO
Other benefits
Company
Beacon Biosignals
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Funding
Current Stage
Growth StageTotal Funding
$116MKey Investors
Catalio Capital Management,Google Ventures,Innoviva,Nexus NeuroTech,S32,TakedaGeneral Catalyst
2025-11-13Series B· $86M
2021-11-08Series A· $27M
2019-06-01Seed· $3M
Recent News
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-12-19
MarketScreener
2025-12-16
Company data provided by crunchbase